{"count": 4, "results": [{"_id": "32995293", "pmid": 32995293, "pmcid": "PMC7501485", "title": "Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: targeting ER-Chaperone GRP78 and Calpain-1 pathways", "journal": "Toxicol Rep", "authors": ["Saleh DO", "Mansour DF", "Mostafa RE"], "date": "2020-09-12T00:00:00Z", "doi": "10.1016/j.toxrep.2020.08.026", "meta_date_publication": "2020", "meta_volume": "7", "meta_issue": "", "meta_pages": "1178-1186", "score": 50245.44, "text_hl": "@CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@RSV@@@ (10 mg/ kg/day) and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@SMV@@@ (10 mg/kg/day) were orally administered for 15 days. ", "citations": {"NLM": "Saleh DO, Mansour DF, Mostafa RE. Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: targeting ER-Chaperone GRP78 and Calpain-1 pathways Toxicol Rep. 2020;7():1178-1186. PMID: 32995293", "BibTeX": "@article{32995293, title={Rosuvastatin and simvastatin attenuate cisplatin-induced cardiotoxicity via disruption of endoplasmic reticulum stress-mediated apoptotic death in rats: targeting ER-Chaperone GRP78 and Calpain-1 pathways}, author={Saleh DO and Mansour DF and Mostafa RE}, journal={Toxicol Rep}, volume={7}, pages={1178-1186}}"}}, {"_id": "12154104", "pmid": 12154104, "title": "Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.", "journal": "Hypertension", "authors": ["Delbosc S", "Cristol JP", "Descomps B", "Mimran A", "Jover B"], "date": "2002-08-01T00:00:00Z", "doi": "10.1161/01.hyp.0000024348.87637.6f", "meta_date_publication": "2002 Aug", "meta_volume": "40", "meta_issue": "2", "meta_pages": "142-7", "score": 50060.03, "text_hl": "The influence of the @GENE_HMGCR @GENE_25675 @@@HMG-CoA reductase@@@ inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was assessed on the @<m>DISEASE_Cardiovascular_Abnormalities</m> @DISEASE_MESH:D018376 @@@cardiovascular alterations@@@ and production of @CHEMICAL_Free_Radicals @CHEMICAL_MESH:D005609 @@@free radicals@@@ associated with chronic @GENE_AGT @GENE_24179 @@@angiotensin II@@@ (@GENE_AGT @GENE_24179 @@@Ang II@@@) infusion. ", "citations": {"NLM": "Delbosc S, Cristol JP, Descomps B, Mimran A, Jover B. Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress. Hypertension. 2002 Aug;40(2):142-7. PMID: 12154104", "BibTeX": "@article{12154104, title={Simvastatin prevents angiotensin II-induced cardiac alteration and oxidative stress.}, author={Delbosc S and Cristol JP and Descomps B and Mimran A and Jover B}, journal={Hypertension}, volume={40}, number={2}, pages={142-7}}"}}, {"_id": "17878758", "pmid": 17878758, "title": "Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.", "journal": "J Cardiovasc Pharmacol", "authors": ["Rugale C", "Delbosc S", "Mimran A", "Jover B"], "date": "2007-09-01T00:00:00Z", "doi": "10.1097/FJC.0b013e3180a72606", "meta_date_publication": "2007 Sep", "meta_volume": "50", "meta_issue": "3", "meta_pages": "293-8", "score": 50048.42, "text_hl": "The ability of the @GENE_HMGCR @GENE_25675 @@@3-hydroxy-3-methylglutaryl-CoA reductase@@@ inhibitor @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ to reverse established @<m>DISEASE_Cardiovascular_Abnormalities</m> @DISEASE_MESH:D018376 @@@cardiovascular and renal alterations@@@ and oxidative stress was assessed in @GENE_AGT @GENE_24179 @@@angiotensin II@@@ (@GENE_AGT @GENE_24179 @@@AngII@@@) @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@. ", "citations": {"NLM": "Rugale C, Delbosc S, Mimran A, Jover B. Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine. J Cardiovasc Pharmacol. 2007 Sep;50(3):293-8. PMID: 17878758", "BibTeX": "@article{17878758, title={Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.}, author={Rugale C and Delbosc S and Mimran A and Jover B}, journal={J Cardiovasc Pharmacol}, volume={50}, number={3}, pages={293-8}}"}}, {"_id": "19856245", "pmid": 19856245, "title": "[Smith-Lemli-Opitz syndrome--case report, diagnostics and therapeutic options].", "journal": "Z Geburtshilfe Neonatol", "authors": ["Oberthür A", "Heller R", "Vogel M", "Körber F", "Rahimi G", "Hoopmann M", "Emmel M", "Roth B", "Vierzig A"], "date": "2009-10-01T00:00:00Z", "doi": "10.1055/s-0029-1224190", "meta_date_publication": "2009 Oct", "meta_volume": "213", "meta_issue": "5", "meta_pages": "210-4", "score": 50038.734, "text_hl": "After the diagnosis had been confirmed, a therapeutic approach with oral substitution of @CHEMICAL_Cholesterol @CHEMICAL_MESH:D002784 @@@cholesterol@@@ and the administration of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was initiated. ", "citations": {"NLM": "Oberthür A, Heller R, Vogel M, Körber F, Rahimi G, Hoopmann M, Emmel M, Roth B, Vierzig A. [Smith-Lemli-Opitz syndrome--case report, diagnostics and therapeutic options]. Z Geburtshilfe Neonatol. 2009 Oct;213(5):210-4. PMID: 19856245", "BibTeX": "@article{19856245, title={[Smith-Lemli-Opitz syndrome--case report, diagnostics and therapeutic options].}, author={Oberthür A and Heller R and Vogel M and Körber F and Rahimi G and Hoopmann M and Emmel M and Roth B and Vierzig A}, journal={Z Geburtshilfe Neonatol}, volume={213}, number={5}, pages={210-4}}"}}]}